Safety and Efficacy of Anti-Oxidants and Anti-inflammatory Agents in Glaucoma and Diabetic Retinopathy

NCT02984813 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

21

Enrollment

OTHER

Sponsor class

Stopped Investigator left the institution

Conditions

Open-angle Glaucoma
Diabetic Retinopathy

Interventions

DRUG: GlaucoHealth
DRUG: GlaucoSelect
DRUG: Placebo

Sponsor

The New York Eye & Ear Infirmary